These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31079796)

  • 21. Successful combination therapy of systemic checkpoint inhibitors and intralesional interleukin-2 in patients with metastatic melanoma with primary therapeutic resistance to checkpoint inhibitors alone.
    Rafei-Shamsabadi D; Lehr S; von Bubnoff D; Meiss F
    Cancer Immunol Immunother; 2019 Sep; 68(9):1417-1428. PubMed ID: 31422446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Promise of Molecularly Targeted and Immunotherapy for Advanced Melanoma.
    Margolin K
    Curr Treat Options Oncol; 2016 Sep; 17(9):48. PubMed ID: 27461037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melanoma Immunotherapy in the Elderly.
    Orloff M
    Curr Oncol Rep; 2018 Mar; 20(2):20. PubMed ID: 29500787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy for melanoma.
    Cuevas LM; Daud AI
    Semin Cutan Med Surg; 2018 Jun; 37(2):127-131. PubMed ID: 30040090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Awareness, understanding, attitude and barriers toward prescribing modern cancer immunotherapies in the Arabian Gulf countries.
    Al-Shamsi HO; Tashkandi E; Bukhari N; Al Farsi A; Alnajjar A; Alhuraiji A; Foheidi M; Sagheir A; Bin Thani K; Al Bahrani B; Alrawi S
    Gulf J Oncolog; 2018 May; 1(27):45-51. PubMed ID: 30145551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging biomarkers as predictors to anti-PD1/PD-L1 therapies in advanced melanoma.
    Loo K; Daud A
    Immunotherapy; 2016 Jun; 8(7):775-84. PubMed ID: 27349977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in malignant melanoma.
    Atkinson V
    Intern Med J; 2017 Oct; 47(10):1114-1121. PubMed ID: 28994264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study.
    Chandran SS; Somerville RPT; Yang JC; Sherry RM; Klebanoff CA; Goff SL; Wunderlich JR; Danforth DN; Zlott D; Paria BC; Sabesan AC; Srivastava AK; Xi L; Pham TH; Raffeld M; White DE; Toomey MA; Rosenberg SA; Kammula US
    Lancet Oncol; 2017 Jun; 18(6):792-802. PubMed ID: 28395880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Active specific immunotherapy with hapten-modified autologous melanoma cell vaccine.
    Sato T
    Cancer Immunol Immunother; 1996 Nov; 43(3):174-9. PubMed ID: 9001571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Geographic variation in posttreatment surveillance intensity for patients with cutaneous melanoma.
    Margenthaler JA; Meier JD; Virgo KS; Johnson DY; Goshima K; Chan D; Handler BS; Johnson FE
    Am J Surg; 2003 Aug; 186(2):194-200. PubMed ID: 12885617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune Checkpoint Inhibitors in Lung Cancer and Melanoma.
    Madden K; Kasler MK
    Semin Oncol Nurs; 2019 Oct; 35(5):150932. PubMed ID: 31561846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Geographic disparities in diagnostic screening for metastatic uveal melanoma.
    Gombos DS; Van Quill KR; Uusitalo M; O'Brien JM
    Ophthalmology; 2004 Dec; 111(12):2254-8. PubMed ID: 15582082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolving systemic targeted therapy strategies in uveal melanoma and implications for ophthalmic management: a review.
    Goh AY; Layton CJ
    Clin Exp Ophthalmol; 2016 Aug; 44(6):509-19. PubMed ID: 26601795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Novel Adjuvant Therapy for Ocular Melanoma].
    Bosch JJ; Heindl LM
    Klin Monbl Augenheilkd; 2017 May; 234(5):670-673. PubMed ID: 28505674
    [No Abstract]   [Full Text] [Related]  

  • 35. How surgeon age affects post-treatment surveillance strategies for melanoma patients.
    Margenthaler JA; Virgo KS; Johnson DY; Sugarbaker EM; Handler BS; Johnson FE
    Int J Oncol; 2001 Jul; 19(1):175-80. PubMed ID: 11408940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity.
    Park J; Talukder AH; Lim SA; Kim K; Pan K; Melendez B; Bradley SD; Jackson KR; Khalili JS; Wang J; Creasy C; Pan BF; Woodman SE; Bernatchez C; Hawke D; Hwu P; Lee KM; Roszik J; Lizée G; Yee C
    Cancer Immunol Res; 2017 Aug; 5(8):618-629. PubMed ID: 28630054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
    Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor stem cell antigens as consolidative active specific immunotherapy: a randomized phase II trial of dendritic cells versus tumor cells in patients with metastatic melanoma.
    Dillman RO; Cornforth AN; Depriest C; McClay EF; Amatruda TT; de Leon C; Ellis RE; Mayorga C; Carbonell D; Cubellis JM
    J Immunother; 2012 Oct; 35(8):641-9. PubMed ID: 22996370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidrugs in the Immunotherapy of Cutaneous and Uveal Melanoma.
    Venza M; Visalli M; Catalano T; Beninati C; Teti D; Venza I
    Anticancer Agents Med Chem; 2017; 17(2):190-205. PubMed ID: 27109020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular genetic and immunotherapeutic targets in metastatic melanoma.
    Melis C; Rogiers A; Bechter O; van den Oord JJ
    Virchows Arch; 2017 Aug; 471(2):281-293. PubMed ID: 28357489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.